Leading Insights in Reproductive Immunology at ASRM
NORTH CHICAGO, Ill. — Rosalind Franklin University proudly announces that Dr. Joanne Kwak-Kim, a celebrated leader in reproductive medicine and immunology, will present at the upcoming Congress of the American Society of Reproductive Medicine (ASRM). This prestigious event serves as a crucial platform for discussing advancements in reproductive medicine, taking place in a vibrant location where top scientists convene.
With over 30 years of relentless dedication to addressing issues related to recurrent pregnancy loss and implantation failure, Dr. Kwak-Kim's contributions to reproductive immunology are invaluable. She plans to present her groundbreaking work on “Endometrial Tissue Analysis: Decidualization Score Test and New Emerging Markers.” This research focuses on the intricate role of natural killer (NK) cells and immune responses in reproduction, shedding light on how these components interact during pregnancy.
Understanding the Maternal Immune Environment
Dr. Kwak-Kim explains that studying endometrial tissue analysis is pivotal in understanding the maternal immune environment, which significantly affects implantation outcomes. “By identifying critical markers associated with decidualization and uterine receptivity, we can approach the complex reasons behind pregnancy failures and explore better supportive measures for early gestation,” she emphasizes.
As a distinguished past-president of the American Society for Reproductive Immunology, Dr. Kwak-Kim boasts an impressive portfolio with 198 peer-reviewed publications. Her expertise continues to shape the landscape of reproductive health.
Collaborative Research and Contributions
In collaboration with Dr. Svetlana Dambaeva, director of RFU’s Clinical Immunology Laboratory, both researchers are set to reveal their findings during the ASRM Congress. Dr. Dambaeva will share several studies, including investigations into the relationships between hormonal levels and NK cell profiles in women facing reproductive challenges.
Key studies presented will explore various aspects, such as:
- The relationship between Anti-Mullerian Hormone and NK cell profiles in women with reproductive failure.
- A model highlighting immune-epithelial dysregulation during polyhydramnios affecting pregnancy.
- Investigation into CXCR4 expression on peripheral blood NK cells and its connection to NK cell activity.
- Immune-ovarian interactions in women lacking autoantibodies.
Emerging Topics in Reproductive Health
Recently, Dr. Kwak-Kim and Dr. Dambaeva, along with their colleagues from the Center for Cancer Cell Biology, Immunology, and Infection, published a pivotal study, pinpointing the dual nature of Interleukin-22 (IL-22) in reproductive health. This study addresses its potential both to protect and endanger pregnancies during inflammatory challenges.
Drs. Kwak-Kim and Dambaeva share their insights, noting, “IL-22 presents an exciting target for therapeutic strategies in reproductive medicine, showing potential not only for preserving pregnancy but also bringing to light the complexities of managing its levels during high-risk conditions.” Their work underscores the significance of immune balance for successful reproductive health outcomes.
Strengthening Reproductive Health Through Collaboration
Dr. Joseph DiMario, the Executive Vice President for Research at RFU, emphasizes the university's integrated approach. “By merging the expertise from our Reproductive Medicine Clinic, Clinical Immunology Laboratory, and various scientific research centers, we provide advanced diagnostic and treatment options for women with histories of implantation failure,” he says.
Each year, RFU serves numerous clinics across multiple countries, undertaking over 40,000 specialized tests aimed at supporting women's reproductive health. This highlights the vital role RFU plays in the ongoing pursuit of knowledge and innovation in this essential field.
Exploring the Future of Reproductive Medicine
The ASRM Congress offers a unique environment for leading clinicians and researchers to exchange ideas that enhance understanding in all domains of reproductive medicine—from fertility challenges to the transition into menopause and emerging technologies that pave the future of this field.
About Rosalind Franklin University
Rosalind Franklin University of Medicine and Science is dedicated to enhancing community health by educating health and biomedical professionals while championing research to improve wellness. Reflecting the spirit of inquiry of its namesake, Dr. Rosalind Franklin, RFU is recognized for its dedication to groundbreaking research spanning various fields, enhancing lives on a global scale.
Frequently Asked Questions
What is the focus of Dr. Kwak-Kim's presentation at ASRM?
Dr. Kwak-Kim will present her research on endometrial tissue analysis, focusing on markers related to implantation and pregnancy success.
Who else is participating in the ASRM Congress from RFU?
Dr. Svetlana Dambaeva will join Dr. Kwak-Kim, presenting multiple studies on reproductive immunology-related topics.
What key insights are highlighted in their recent study on IL-22?
The study discusses IL-22's potential to protect pregnancies while also highlighting the risks associated with its elevated levels.
How does RFU contribute to advancements in reproductive health?
RFU integrates clinical research and laboratory findings to provide advanced diagnostic services and treatments for women's reproductive issues.
What is the significance of the ASRM Congress?
The ASRM Congress brings together top professionals to foster discussion and innovation in reproductive medicine, addressing a wide range of reproductive health topics.
